eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

Bristol-Myers Squibb Pharmaceutical Limited

Bristol-Myers Squibb House, Uxbridge Business Park, Sanderson Road, Uxbridge, Middlesex, UB8 1DH , UK
Telephone: +44 (0)1895 523 000
Fax: +44 (0)1895 523 010
Medical Information Direct Line: +44 (0)1895 523 740
Medical Information e-mail: medical.information@bms.com
Medical Information Fax: +44 (0)1895 523 677

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Patient Information Leaflet last updated on the eMC: 26/04/2012
PIL Nalorex

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 26/04/2012 and displayed until Current
Reasons for adding or updating:
  • Updates to formatting
  • Correction of spelling/typing errors
Updated on 13/03/2012 and displayed until 26/04/2012
Reasons for adding or updating:
  • Change/addition of instructions for reconstitution and/ or administration
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to information about pregnancy or lactation
Updated on 05/02/2010 and displayed until 13/03/2012
Reasons for adding or updating:
  • Change to packaging
  • Change to date of revision
  • Change to storage instructions
Updated on 25/07/2008 and displayed until 05/02/2010
Reasons for adding or updating:
  • Change to storage instructions
Updated on 07/09/2006 and displayed until 25/07/2008
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Active Ingredients/Generics

 
   naltrexone hydrochloride